Consequently, there is strong evidence that E2-stimulated cAMP likely enhances PP1Cα activity via PKA, which binds to BIG3, resulting in the dephosphorylation of PHB2-S39, suggesting that BIG3 acts as an AKAP for E2 signalling activation in luminal breast cancer. Here, ARFGEF3 is linked to breast carcinoma.